Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPenn State University
About this trial
In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.
Eligibility criteria
Qualifiers
Adults (18+) with overweight or obesity (BMI >25 kg/m2)
Not currently taking an incretin-based medication at baseline
Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
Disqualifiers
Adults (18+) without overweight or obesity
<18 years of age at time of testing
Adults not taking a GLP-1 Medication
Adults taking a compound GLP-1
Trial design
Treatments tested in this trial
- GLP-1 Medication Initiation
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov